Viral Hepatitis
Copyright ©The Author(s) 2003.
World J Gastroenterol. Apr 15, 2003; 9(4): 751-754
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.751
Table 1 The detective results of HCV-RNA in serum and PBMC after treatment with alpha 2b interferon (n, %)
GroupnHCV-RNA in PBMC
HCV-RNA in serum
Anti-HCV
NegativeNegative rateNegativeNegative rateNegativeNegative rate
Interferon261142.31a1557.69a1765.38b
treatment
Routin22313.64522.73627.27
treatment
Table 2 The results of negative rate of HCV-RNA in serum and PBMC
HCV-RNA in serumHCV-RNA in PBMC
Totalχ2P
+-
+7411
-87150.75> 0.05
Total151126
Table 3 The level of mIL-2R before and after treatment of in-terferon (n, x-± s, %)
GroupnmIL-2R (in silence)
mIL-2R (inducement)
Before treatmentAfter treatmentBefore treatmentAfter treatment
Interferon treatment262.63 ± 0.703.44 ± 0.77bcd30.34 ± 3.5533.62 ± 3.95cd
Routin treatment222.43 ± 0.782.95 ± 0.72ad30.07 ± 3.8730.04 ± 3.73d
Normal control204.54 ± 1.4837.42 ± 4.10